ClinicalTrials.govpublic full text
Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)
coronary artery disease, dyslipidemias
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 184750
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.